Literature DB >> 12914697

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

Justin Lamb1, Sridhar Ramaswamy, Heide L Ford, Bernardo Contreras, Robert V Martinez, Frances S Kittrell, Cynthia A Zahnow, Nick Patterson, Todd R Golub, Mark E Ewen.   

Abstract

Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-Il6, participates in the consequences of cyclin D1 overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914697     DOI: 10.1016/s0092-8674(03)00570-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  164 in total

1.  CONFAC: automated application of comparative genomic promoter analysis to DNA microarray datasets.

Authors:  Suresh Karanam; Carlos S Moreno
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

Review 2.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

3.  Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

Authors:  Roberto Piva; Elisa Pellegrino; Michela Mattioli; Luca Agnelli; Luigia Lombardi; Francesco Boccalatte; Giulia Costa; Bruce A Ruggeri; Mangeng Cheng; Roberto Chiarle; Giorgio Palestro; Antonino Neri; Giorgio Inghirami
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

4.  A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility.

Authors:  Jennifer L Shepard; James F Amatruda; Howard M Stern; Aravind Subramanian; David Finkelstein; James Ziai; K Rose Finley; Kathleen L Pfaff; Candace Hersey; Yi Zhou; Bruce Barut; Matthew Freedman; Charles Lee; Jan Spitsbergen; Donna Neuberg; Gerhard Weber; Todd R Golub; Jonathan N Glickman; Jeffery L Kutok; Jon C Aster; Leonard I Zon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

5.  Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.

Authors:  Yan Li; Wei Yin; Xia Wang; Wenbo Zhu; Yijun Huang; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

6.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Authors:  Brenda R Baldwin; Nikolai A Timchenko; Cynthia A Zahnow
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 7.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

8.  Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.

Authors:  Bao-Ping Luo; Jing Luo; Yi-Bing Hu; Xiao-Wei Yao; Feng-Hua Wu
Journal:  Curr Med Sci       Date:  2018-06-22

9.  GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.

Authors:  Clemens R Scherzer; Jeffrey A Grass; Zhixiang Liao; Imelda Pepivani; Bin Zheng; Aron C Eklund; Paul A Ney; Juliana Ng; Meghan McGoldrick; Brit Mollenhauer; Emery H Bresnick; Michael G Schlossmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

Review 10.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.